Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

How to access Pharma in Focus articles
  • If you're a current subscriber, See below

  • If you're new to Pharma in Focus, Click here

  • If you haven't SUBSCRIBED yet, Click here

Current Subscribers

If you are are current Full Text Subscriber or have taken out a Free Trial, please type your email address into the form below.

This will restore your access and return you to the Home Page.

Email Address
Pipeline Monitor
Lilly wins first new approval since '09
Eli Lillys Cyramza has been approved by the FDA for advanced stomach cancer in the company's first new drug approval since 2009; plus GSK's Arzerra gains first line, AbbVie files hep C combo.
Working Life
Getting healthy at the office
Yoga, pilates and boxercise in the office. An increasing number of pharmacos are investing in more than just a healthy bottom line, writes Karen Keast.
Approvals Action
New COPD med gets TGA nod
As GlaxoSmithKline waits for the PBAC to respond to it submission for PBS reimbursement of COPD and asthma treatment Breo Ellipta, it can celebrate TGA market approval.